Recursion Pharmaceuticals: Q1 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Thursday reported a loss of $91.4 million in its first quarter.

On a per-share basis, the Salt Lake City-based company said it had a loss of 39 cents.

The biotechnology company posted revenue of $13.8 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $13.4 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RXRX at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up